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ABSTRACT 
 
Obesity is associated with increased risk for chronic migraine and migraine progression, 
but associations with episodic migraine (EM) and episodic tension-type headache (TTH) are 
unclear. Most studies have relied on BMI as an indicator of adiposity. More accurate 
anthropometric measures that distinguish adipose tissue from other body tissue are critical to 
examine adiposity-headache associations, including validated measures of abdominal adiposity 
and established measurement formulas such as body adiposity index (BAI) and body 
composition equations developed by Peterson et al. (2003) and Garcia et al. (2005). The present 
study explored adiposity-headache associations by employing established anthropometric 
measures of adiposity and comparing individuals with migraine, with TTH, and without 
headache. 
Participants were 109 young adults meeting ICHD-3 criteria for TTH or migraine, or 
without headache. Ninety-three percent of migraineurs had EM, and 92.5% of TTH sufferers had 
ETTH. Researchers measured each participant and calculated adiposity as a function of: BMI, 
waist circumference, BAI, waist-to-hip ratio, and the aforementioned body composition 
equations. Headache severity and frequency were obtained via diagnostic interview (SDIH-3), 
and headache-related disability was assessed by the Headache Impact Test (HIT-6). 
MANOVA and a subsequent MANCOVA did not reveal significant differences in 
adiposity between migraine, TTH, and non-headache groups. Regression analyses indicated that 
among migraineurs, adiposity accounted for 11%, 13%, and 10% of the variance in headache 
severity, frequency, and disability, respectively, though these proportions were not statistically 
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significant. Among participants with TTH, adiposity accounted for 8% (p = .82), 21% (p =.23), 
and 39% (p = .009) of the variance in headache severity, frequency, and disability. The
association with disability among those with TTH fell short of significance after Bonferroni 
correction for multiple comparisons.  
Adiposity did not differ between headache groups, and no significant associations were 
found between adiposity and headache frequency, severity, and disability. Findings extend upon 
existing literature that has established a positive association between obesity and chronic 
headache, suggesting that adiposity may not be a distinguishing characteristic among individuals 
with EM and ETTH. Longitudinal studies that employ gold standard methods of adiposity 
measurement among diverse samples are needed to further clarify the role of adiposity in 
headache. 
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I.  INTRODUCTION 
Migraine and Tension-Type Headache: Definitions and Impact 
The International Classification of Headache Disorders (ICHD-3; International Headache 
Society, 2013) differentiates the diagnostic criteria for all headache disorders, including migraine 
and tension-type headache (TTH). Migraine is characterized by a unilateral location, pulsating 
quality, moderate or severe pain intensity, and/or interference with routine physical activity. 
Headache attacks last 4-72 hours and may be accompanied by nausea, vomiting, photophobia, 
and/or phonophobia. While a diagnosis of episodic migraine (EM) requires at least five lifetime 
attacks, a diagnosis of chronic migraine (CM) requires at least 15 days with headache per month 
for a period of several months. 
Migraine is a common neurological disorder that can be very disabling, with a 12% 
lifetime prevalence in the U.S (Lipton et al., 2007). Migraine is three times more common 
among women than men (18% vs. 6%, respectively; Lipton et al., 2007; Lipton, Bigal, 
Hamelsky, & Scher, 2008). Although migraine can affect people throughout their lives, peak 
prevalence is between the ages of 30-39 among both men and women, with lowest occurrence in 
adults aged 60 or over. Research has consistently confirmed that individuals with migraine 
experience many negative consequences as a result of the disorder, including reduced quality of 
life (Lipton, Hamelsky, Kolodner, Steiner, & Stewart, 2000; Terwindt et al., 2000), reduced 
work performance (Von Korff, Stewart, Simon, & Lipton, 1998), reduced school functioning 
(Smitherman, McDermott, & Buchanan, 2011), frequent medical visits (Edmeads et al., 1993), 
and negative impact on family relationships. 
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Tension-type headache (TTH) is characterized by symptoms typically opposite those of 
migraine, including bilateral location, a pressing or tightening quality, and mild to moderate 
intensity; TTH is not aggravated by routine physical activity. Headaches last from 30 minutes to 
7 days and may be accompanied by photophobia or phonophobia (but not both). ICDH-3 
specifies three different types of TTH based on headache frequency: infrequent episodic TTH 
occurring one day or less per month, frequent episodic TTH occurring 1-14 days per month, and 
chronic TTH with 15 or more headache days per month.  
Tension-type headache is the most common primary headache disorder, affecting an 
estimated 38% of the U.S. population annually (Schwartz, Stewart, Simon, & Lipton, 1998); 
similar rates are found in other countries (Da Costa, Soares, & Heinisch, 2002; Pop, Gierveld, 
Karis, & Tiedink, 2002). Lifetime prevalence may be as high as 87% (Lyngberg, Rasmussen, 
Jørgensen, & Jensen, 2005). Although similar to migraine in being more common among 
females and having a peak prevalence between the ages of 30 and 39, gender differences in TTH 
prevalence are less pronounced, with the male:female ratio being 1:1.1-1.4 (Lyngberg et al., 
2005). 
Comorbidities of Migraine and TTH 
Extensive literature supports an association of migraine with psychiatric disorders, 
including major depressive disorder, panic disorder, phobias, and bipolar disorder (Baskin, 
Lipchik, & Smitherman, 2006; Baskin & Smitherman, 2009; Jette, Patten, Williams, Becker, & 
Wiebe, 2008; Lipton, Hamelsky, Kolodner, Steiner, & Stewart, 2000; Ratcliffe, Enns, Jacobi, 
Belik, & Sareen, 2009). Other comorbid disorders include generalized anxiety disorder and 
obsessive-compulsive disorder, although prevalence of these comorbid disorders among 
migraineurs varies between studies (Breslau, Davis, & Andreski, 1991; Swartz, Pratt, Armenian, 
Lee, Eaton, 2000; Jette et al., 2008; Ratcliffe et al., 2009). Studies comparing EM and CM have 
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found that rates of psychiatric disorders are higher among individuals with CM (Antonaci et al., 
2011). Migraineurs are also at increased risk for sleep disorders, especially insomnia (Rains & 
Poceta, 2006). 
Depression, anxiety, and panic disorder are more prevalent among individuals with TTH 
compared to non-headache controls, particularly those with CTTH (Crystal & Robbins, 2010), as 
some studies have found no difference in psychiatric comorbidity rates between individuals with 
ETTH and those without headache (Merikangas, Stevens, & Angst, 1993; Merikangas, 1994). 
Fatigue and sleep disorders have also been found to be more prevalent among TTH sufferers 
than non-headache controls (Rasmussen, 1993). 
In addition to these psychiatric comorbidities, researchers have most recently shown 
interest in the comorbidity between obesity and headache. 
Obesity 
Obese and overweight denote ranges of weight that the Centers for Disease Control and 
Prevention has established as greater than a healthy weight for a given height (“Defining,” 2012). 
Both weight ranges increase risk for numerous diseases and health problems. Although the body 
mass index (BMI) is not a direct measure of adipose tissue, the CDC defines overweight and 
obese categories according to BMI values. BMI is a function of the ratio of weight to height and 
calculated via the following equation: BMI = Weight(kg) / Height(m)2. BMI values between 18.5 
and 24.9 indicate a healthy weight, 25 - 29.9 overweight, and 30 or greater obese. The American 
Heart Association categorizes BMI values between 35 and 39.9 as “moderate” obesity and BMI 
values of 40 or greater as “severe” obesity (Cornier et al., 2011). The World Health Organization 
defines abdominal obesity – an alternative measure of obesity – as a waist circumference greater 
than 88 centimeters (for women) and as a waist circumference greater than 102 centimeters (for 
men; Peterlin, Rosso, Rapoport, & Scher, 2010). 
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Using BMI as the metric, obesity prevalence among youth and adults in the U.S. has been 
increasing for the past several decades. Currently, an estimated 34.9% of U.S. adults are obese, 
along with 16.9% of U.S. children and adolescents (Ogden, Carroll, Kit, & Flegal, 2014). These 
rates represent nearly three-fold increases since the 1960s, when the adult obesity rate was 13% 
and the child rate was approximately 5%. In addition to the drastic rise in obesity rates, the 
number of children and adults who are overweight has also increased dramatically. An estimated 
33.6% of adults in the U.S. are currently overweight but not obese, making the total number of 
adults who are above a healthy weight approximately 68.5%. A similar trend is seen among 
children, with 14.9% being overweight but not obese and 31.8% weighing above a healthy 
weight (Ogden et al., 2014). 
The National Institutes of Health (NIH) has declared obesity a major public health 
challenge in the U.S., citing obesity as a major contributor to preventable death. Obesity 
substantially increases risk for hypertension, type 2 diabetes, coronary heart disease, 
dyslipidemia, stroke, osteoarthritis, gallbladder disease, sleep apnea, respiratory problems, and 
certain cancers (Expert Panel, 1998). Most recently, headache researchers have attempted to 
ascertain the role of obesity in headache disorders.  
Obesity and Headache 
A relationship between obesity and headache was first suggested in 2000. In a population 
based cross-sectional study, Brown, Mishra, Kenardy, and Dobson (2000) examined a sample of 
14,779 women between the ages of 18 and 23 who self-reported their height and weight along 
with various medical conditions and symptoms. Obese women, as defined by a BMI of 30 or 
greater, were 47% more likely to report headache than women with a BMI less than 30. In this 
study, Brown and colleagues did not differentiate among headache diagnoses. In another 
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population-based study with over 55,000 participants and self-reported height, weight, and 
headache frequency, Scher, Stewart, Ricci, and Lipton (2003) found the prevalence of chronic 
daily headache to be higher (OR = 1.34) among individuals with BMIs greater than 30 compared 
to those with BMIs within the normal range. An additional finding in Scher et al.’s study was 
that among participants who had reported episodic headache at baseline, those with BMIs greater 
than 30 were five times as likely as those with normal BMIs to have progressed to chronic daily 
headache at 11-month follow-up, suggesting that obesity may be a risk factor for headache 
chronification. 
Obesity and Migraine 
 Most of the research on obesity and headache has specifically focused on associations 
between obesity and migraine prevalence, and few studies have differentiated episodic from 
chronic migraine in their samples. However, these studies have consistently found a positive 
association between BMI and migraine prevalence. Ford, Li, Pearson, Zhao, Strine, and Mokdad 
(2008) examined data from the National Health and Nutrition Examination Survey 1999–2002, 
which included over 7000 U.S. men and women ages 20 and older. Although Ford et al. (2008) 
directly measured height and weight, they did not differentiate headache diagnoses or adhere to 
ICHD criteria. Rather, they asked participants, “During the past 3 months, did you have severe 
headaches or migraines?” Logistic regression analyses confirmed that participants with BMIs 
greater than 30 were 37% more likely (OR = 1.37) than those of normal weight to endorse the 
occurrence of severe headaches or migraines. In a study of 3,733 women who were in the early 
stages of pregnancy, Vo, Ainalem, Qiu, Peterlin, Aurora, and Williams (2011) also found that 
obese women were more likely than women of normal weight to have had a diagnosis of 
migraine (OR = 1.48). Height and weight were self-reported in this study, and migraine was 
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defined as a positive response to the question, “Has a doctor ever told you that you have 
migraine headache?” Additionally, analyses revealed that migraine prevalence increased as BMI 
increased, such that morbidly obese (OR = 2.07; BMI = 35-39.9) and extremely obese (OR = 
2.75; BMI ≥ 40) women were at increased risk for migraine compared to those of normal weight. 
Further, women with migraine as children had 1.67-fold increased odds of gaining at least 10 
kilograms during adulthood, suggesting that migraine may also predispose one to obesity.  
 Age, gender, and adipose tissue distribution affect the association between obesity and 
migraine. In a U.S. sample of 10,623 men and 11,160 women whose height and weight were 
directly measured and who responded to the question, “During the past 3 months, did you have 
severe headaches or migraines?”, Peterlin, Rosso, Rapoport, and Scher (2010) found that obesity 
(BMI > 30) was associated with increased migraine prevalence among both men (OR = 1.38) 
and women (OR = 1.2) under the age of 55. They found no association between BMI and 
migraine prevalence among men and women over the age of 55. In this same study, Peterlin et al. 
(2010) included waist circumference (WC) as an additional measure of obesity and observed that 
migraine prevalence in obese participants varied as a function of sex, age, and adipose tissue 
distribution pattern. Independent of total body obesity (as estimated by BMI), women with 
abdominal obesity (> 88cm) under the age of 55 were at increased risk for migraine (OR = 1.26), 
but women with abdominal obesity over the age of 55 were at decreased risk for migraine (OR = 
.73). Among men of all ages, abdominal obesity (> 102cm) was not associated with migraine 
prevalence when controlling for total body obesity. Peterlin et al. concluded that gender 
differences may be a result of the sexual dimorphism of adipose tissue distribution: Men deposit 
adipose tissue in the abdominal region throughout adulthood, while women deposit adipose 
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tissue primarily in the gluteofemoral region until after menopause, at which point they also 
deposit adipose tissue abdominally (Peterlin et al., 2010). 
Although abdominal and total body obesity are associated with an increased risk of 
migraine among women under age 55, studies have demonstrated consistently that obesity is not 
associated with increased risk for migraine or migraine-related variables in women over the age 
of 45 or in men over the age of 55 (Keith, Wang, Fontaine, Cowan, & Allison, 2008; Mattsson, 
2007; Peterlin et al., 2013; Peterlin, Rosso, Rapoport, & Scher, 2010; Winter, Berger, Buring, & 
Kurth, 2009). 
Although migraine is not positively associated with obesity among adults of post-
reproductive age, both migraine frequency and migraine-related disability are positively 
associated with BMI among adults over age 18. Tietjen, et al. (2007) collected data from eight 
U.S. outpatient headache centers on 721 patients who met ICHD-II criteria for episodic or 
chronic migraine. Participants self-reported their height and weight. Tietjen et al. (2007) found 
positive associations between BMI and migraine frequency/disability, although these 
associations were no longer significant when controlling for depression and anxiety. However, 
compared to migraineurs within a normal BMI range and without depression or anxiety, 
likelihood of higher migraine frequency increased as a function of BMI for those with depression 
[normal (OR = 2.63), overweight (OR = 3.26), obese (OR = 4.16)] and for those with anxiety 
[overweight (OR = 2.17), obese (OR = 1.96)]. Similarly, normal (OR = 4.19), overweight (OR = 
6.68), and obese (OR = 7.1) migraineurs with depression were at increased risk for migraine-
related disability, as were normal (OR = 2.24), overweight (OR = 6.05), and obese (OR = 3.59) 
migraineurs with anxiety. Migraineurs with concomitant depression and anxiety were the most 
likely to have higher migraine frequency and migraine-related disability. Results suggested that 
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the positive association between BMI and migraine frequency/disability may be largely 
explained by comorbid depression and anxiety symptoms that commonly occur with both 
migraine and obesity (Tietjen et al., 2007). 
 In addition to depression and anxiety being moderators in the positive association 
between BMI and migraine frequency/disability, race is another potential moderator, although 
most studies have included primarily White participants in America and European countries. 
However, Yu et al. (2012) conducted a study of 5,041 adults throughout China, directly 
measuring participant height and weight and assessing migraine based on ICHD-II criteria. 
Although no association between BMI and prevalence of migraine was observed among 
participants with a BMI less than 30, those with a BMI greater than 30 were twice as likely as 
those with BMIs between 18.5 and 23 to have a diagnosis of migraine (OR = 2.1). However, 
contrary to studies with primarily White samples, Yu and colleagues found no relationship 
between BMI and other migraine variables (i.e., severity, frequency, or disability), suggesting 
that different BMI-migraine associations may exist for different ethnicities. Both obesity rates 
(Ogden et al., 2014) and body fat distribution patterns (Rahman, Temple, Breitkopf, & Berenson, 
2009) vary across races, however, which may influence BMI-migraine associations. 
Obesity in Relation to Chronic Migraine and Chronic Tension-Type Headache 
 Studies to date indicate that CM prevalence is higher among people who are obese 
compared to those of normal weight, although differences in prevalence of CTTH between those 
who are obese vs. normal weight are unclear. Bigal and Lipton (2006) surveyed individuals 
between 18 and 89 who self-reported their height and weight. Unlike prior studies, Bigal and 
Lipton differentiated CM from CTTH. Of 30,849 participants, 1243 (4%) met criteria for chronic 
daily headache (CDH), 1.3% with CM and 2.8% with CTTH. BMI had an influence on CM 
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prevalence, such that while CM prevalence among participants of normal weight was 0.9%, it 
increased to 1.2% in overweight (OR = 1.4), 1.6% in obese (OR = 1.7), and 2.5% in morbidly 
obese (OR = 2.2) participants. However, Bigal and Lipton did not find this positive association 
between BMI and headache among participants with CTTH, as prevalence was not different 
between normal weight, overweight, and obese, although participants categorized as morbidly 
obese (BMI > 35) did exhibit a significantly higher rate of CTTH (OR = 1.4). 
 Schramm, Obermann, Katsarava, Diener, Moebus, and Yoon (2013) also compared the 
prevalence of CTTH and CM in a population-based study in Germany that included over 7,000 
participants with headache. 108 met ICHD-II criteria for CM and 50 met criteria for CTTH. 
Participants who met criteria for CM were more likely to be obese (using self-reported height 
and weight) than those with CTTH (OR = 1.86) and without any headache diagnosis (OR = 
1.39). However, Schramm et al. also found the positive association between CM and obesity was 
no longer evident after controlling for acute pain medication use (OR = .85), though it remained 
among CTTH participants (OR = 1.85). 
 Further highlighting the role of obesity in frequent headache, Bigal and Lipton (2006) 
assessed the proportion of CDH sufferers with daily headache as a function of BMI. While 36% 
of CDH sufferers of normal weight reported daily headaches, 48.7% [OR = 1.5] of obese 
participants reported daily headaches, as did 51% [OR = 1.7] of the morbidly obese. This 
positive association between BMI and headache frequency was not observed among participants 
with CTTH. Similarly, the proportion of chronic migraineurs who reported missing at least three 
days of work during the previous three months and/or who reported severe pain in more than 
50% of attacks was significantly higher among the overweight, obese, and morbidly obese when 
compared to those of normal weight. Bigal and Lipton (2006) concluded the association between 
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headache and obesity is stronger for CM than for CTTH, although Schramm et al.’s (2013) 
findings suggest that this conclusion may be a function of patterns of acute pain medication use. 
Obesity and Episodic Migraine 
Although research has consistently demonstrated that migraine prevalence is higher 
among individuals meeting criteria for obesity, most studies did not differentiate between CM 
and EM. The two existing studies on EM and obesity have yielded conflicting results regarding 
the association between obesity and migraine prevalence, even though both adhered to ICHD 
criteria for EM diagnosis and relied on self-reported height and weight for BMI calculations. In a 
U.S. sample including 3,791 episodic migraineurs, Bigal, Liberman, and Lipton (2006) found the 
prevalence of EM did not significantly differ as a function of BMI for any age or gender. 
However, another U.S. study using data from a nationally representative survey (National 
Comorbidity Survey Replication; Kessler et al., 2004) that included 188 episodic migraineurs 
found BMI was positively associated with EM prevalence among females under age 50 (Peterlin 
et al., 2013). They did not find any association between obesity and migraine prevalence among 
males. Stratified analyses indicated increased EM prevalence in obese participants compared 
with normal-weight participants among those who were younger than age 50 (OR = 1.86), white 
(OR = 2.06), and female (OR = 1.95), suggesting the association between EM prevalence and 
obesity is strongest among these subgroups. 
Both studies also reached different conclusions regarding the association between obesity 
and EM frequency. Peterlin et al. (2013) found no association between BMI and migraine 
frequency, while Bigal et al. (2006) found that number of headache days per month increased as 
a function of BMI. While only 4.4% of the normal weight group had 10-15 headache days per 
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month, 5.8% of overweight (OR = 1.3), 13.6% of obese (OR = 2.9), and 20.7% of morbidly 
obese (OR = 5.7) had headache of this high frequency. 
Bigal et al. (2006) also found that the proportion of migraineurs reporting severe attacks 
increased with BMI. 53% of normal-weight participants endorsed severe migraine attacks, while 
57% of the overweight (OR = 1.25), 59% of the obese (OR = 1.31), and 65% of the morbidly 
obese (OR = 1.9) participants had severe attacks. Obese (OR = 1.5) and morbidly obese (OR = 2) 
participants were also more likely to report missing at least one day of school or work each 
month due to migraine, indicating greater migraine-related disability. This is the only study to 
date that has examined migraine severity and disability specifically among episodic migraineurs. 
Adiposity Measurement 
In research on obesity, including research on headache-obesity associations, BMI is 
widely used as a measure of adiposity due to its accessibility and simplicity (Cornier et al., 
2011). However, BMI is a measure of body mass specifically and thus does not quantify body 
composition. BMI does not distinguish between lean and fat body mass, making it possible for 
an individual with a “normal” BMI value to actually have a higher-than-normal percent body fat, 
or for one with a “high” BMI to have a body composition of mostly lean (non-adipose) tissue. 
BMI thus inaccurately quantifies the adiposity of many individuals, particularly those with 
excess adipose tissue. Okorodudu et al. (2010) conducted a meta-analysis of 32 studies 
examining the accuracy of BMI in terms of adiposity measurement and concluded that BMI had 
an overall sensitivity of 50%, indicating that half of individuals with excess adipose tissue were 
misclassified as being of normal weight. However, BMI had a specificity of 90% to identify 
excess body adiposity, meaning that BMI usually correctly identifies those who are not obese. 
Among male athletes, Pivarnik, Reeves, and Knous (2007) found that specificity of BMI to 
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diagnose excess adiposity was only 27%, such that BMI inaccurately categorized 73% of their 
healthy-weight sample as obese.  
 In light of the poor sensitivity of BMI, debate exists regarding the most accurate method 
of measuring adiposity. Cadaver analysis is the only measure of body composition with 100% 
sensitivity and specificity; thus, no perfect measure exists for use in clinical settings (Hu, 2008). 
Currently, the most thorough assessment of body composition is a “four-component model” (i.e., 
four-compartment model), which requires precise measurement and quantification of water, 
mineral, fat, and protein levels in the body (Fuller, Jebb, Laskey, Coward, & Elia, 1992; 
Williams et al., 2006). Given the resources and time required, the four-component model has 
limited clinical utility. In its stead several single-procedure methods have been promoted after 
being validated against the four-component model, and each is considered to be reliable in 
estimating percent body fat and/or fat distribution (Hu, 2008). These include dual-energy X-ray 
absorptiometry (DEXA), densitometry or underwater weighing, air-displacement 
plethysmography, hydrometry or dilution, and imaging in the form of computerized tomography 
(CT) and magnetic resonance (MRI) (Hu, 2008). When compared to the four-component model, 
CT and MRI combined consistently exemplify the highest level of accuracy (Hu, 2008; Ross & 
Janssen, 2005; Ross, 2003). 
Studies examining associations between adiposity and headache would ideally rely on at 
least one of these methods to determine percent body fat and fat distribution. However, utility 
lies in more practical and affordable methods of quantifying obesity that are appropriate to 
clinical settings. Anthropometric measurements are noninvasive, quantitative techniques for 
determining body fat composition by measuring, recording, and analyzing specific dimensions of 
the body (Hu, 2008) such as waist circumference, hip circumference, neck circumference, thigh 
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circumference, ratios (waist-to-hip, waist-to-height, waist-to-thigh), skinfold thickness, and body 
adiposity index (BAI). Of these, waist circumference, waist-to-hip ratio, BAI, and skinfold 
thickness equations have the most literature supporting their validity in quantifying overall 
adiposity and fat distribution. 
Waist circumference and waist-to-hip ratio are both acceptable measures of central 
(abdominal) adiposity, and some evidence suggests than waist circumference may be a superior 
measure to waist-to-hip ratio (Clasey et al., 1999; Kamel et al., 1999). The World Health 
Organization (2011) defines abdominal obesity for women as a waist circumference greater than 
88 centimeters or a waist-to-hip ratio greater than .85; and for men as a waist circumference 
greater than 102 centimeters or a waist-to-hip ratio greater than .9. Clasey et al. (1999) compared 
various anthropometric measures to results of CT scans and found waist circumference to have 
high correlations with total abdominal fat (r = .87 to .93) and abdominal visceral fat (r = .84 to 
.93). Kamel et al. (1999) found waist-to-hip ratio, waist circumference, and DEXA scans to 
predict intra-abdominal fat in men equally well as MRI, although among women, DEXA was a 
more accurate predictor.  
The Body Adiposity Index (BAI) is a mathematical formula that uses height and hip 
circumference to estimate percent body fat (Bergman et al., 2012). The formula is: BAI = ((hip 
circumference in cm)/((height in m)1.5)–18)). Bergman and colleagues used DEXA scanners to 
determine percent body fat in over 1700 Mexican-Americans and derived a formula in 
comparison to the DEXA data. They then validated their equation using data from a separate 
study of African-Americans and found a high correlation between BAI and DEXA-determined 
percent body fat (R = .85) and a Lin's concordance correlation coefficient of .95. Johnson, 
Chumlea, Czerwinski, and Demerath (2012) further validated the BAI in a sample of over 600 
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Whites age 20-50 and concluded that the BAI was a “robust” equation applicable to their sample. 
In spite of the applicability of the equation to multiple ethnicities and the ease of measurement 
and calculation, BAI is not as accurate in estimating percent body fat as DEXA scans and CT or 
MRI and is thus not a true surrogate measure for percent body fat. BAI may, however, be a more 
accurate predictor than BMI given its greater concordance with percent fat (ρc = 0.752 vs ρc = 
0.445 for BMI) and given its significantly stronger correlation with DEXA-measured percent fat 
(Johnson et al., 2012). 
 Another method of assessing adiposity that has been compared to the four-component 
model is measurement of skinfold thickness. No universally accepted method for estimating 
body fat based on skinfolds exists, and many equations have been promoted. All involve 
pinching the skin with the thumb and index finger and placing a pair of calipers on the fold to 
measure the thickness of two layers of skin and the underlying fat. In a review of anthropometric 
methods, Cornier et al. (2011) recommend measuring each skinfold site three times, and taking 
the average of those three measurements as the final value for that site. Cornier et al. further 
recommend that variance between readings should not be more than one millimeter, otherwise 
measurements should continue until three readings agree within one millimeter. The two most 
widely used methods were published by Durnin and Womersley (1974) and Jackson and Pollock 
(1978; 1979). However, both of these methods were based on the two-component model, which 
separates the composition of the body into fat mass and fat-free mass. Since then, researchers 
have developed different skinfold equations based on the four-component model (Fuller, Jebb, 
Laskey, Coward, & Elia, 1992), and study results indicate these equations are more accurate than 
the original methods (Peterson, Czerwinski, & Siervogel, 2003; Garcia et al., 2005). 
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Peterson, Czerwinski, and Siervogel (2003) determined percent body fat in a sample of 
over 600 Whites ages 18-55 in the U.S. by using DEXA scans, total body water assessment, and 
hydrodensitometry – measurements allowing for conformity to the four-component model. To 
aid in determining skinfold equations, they measured seven skinfold sites (triceps, subscapular, 
biceps, midaxillary, suprailiac, midthigh, and lateral calf) and five circumferences (abdomen, 
hip, thigh, calf, and upper arm). Using a series of regression analyses, they developed skinfold 
equations for women and men to predict percent body fat in adults. The final equations were as 
follows: 
For men: %BFnew = 20.94878 + (age × 0.1166) 
- (height × 0.11666) + (sum4 × 0.42696) 
- (sum42 × 0.00159) 
 
For women: %BFnew = 22.18945 + (age × 0.06368) 
+ (BMI × 0.60404) - (height × 0.14520) 
+ (sum4 × 0.30919) - (sum42 × 0.00099562) 
 
Height is quantified in cm and “sum4” is the sum of the triceps, subscapular, suprailiac, and 
midthigh skinfold thicknesses. Within a cross-validation group, percent body fat as quantified by 
the skinfold equations did not differ significantly from percent body fat quantified by the four-
component model (%BF4C; Peterson et al., 2003). The authors also validated the widely used 
Durnin and Womersley (1974; %BFDW) and Jackson and Pollock (1978; 1979; %BFJP) equations 
against the four-component model and found %BFDW and %BFJP to underestimate percent body 
fat, with mean underestimations of 2.4-3.1% and 6.6% respectively. Precision, as determined by 
root mean square error (RMSE) values of predicted %BF in the cross-validation groups, was 
similar for all skinfold equations, ranging between 4.6% and 5%. Peterson and colleague’s 
equation was thus a more accurate and equally precise estimate of percent body fat compared to 
Durnin and Womersley’s and Jackson and Pollock’s equations. 
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 Garcia et al. (2005) developed a skinfold equation that also took bone-breadths (chest, 
elbow, knee, wrist, ankle), additional skinfolds (chin, biceps, triceps, subscapular, chest, 
abdominal, hip, thigh, knee, calf), and circumferences (waist, hip, thigh) into account. Using 
DEXA as their reference method, researchers measured body fat in 117 German males and 
females between the ages of 26 and 66 with a BMI range of 19.0 to 39.4 kg/m2. The equations 
for body fat mass (BFMNew) most predictive of body fat mass as determined by DEXA 
(BFMDexa) and cross-validated in a separate sample were: 
BFMNew (kg) for men = -40.750 + {(0.397 × waist circumference) + 
[6.568 × (log triceps SF + log subscapular SF + log abdominal SF)]} 
 
BFMNew (kg) for women = -75.231 + {(0.512 × hip circumference) + [8.889 
× (log chin SF + log triceps SF + log subscapular SF)] + (1.905 × knee breadth)} 
 
BFMNew correlated highly with BFMDexa in both men (r = 0.938, p < 0.001) and women (r = 
0.949, p < 0.001). Mean differences between percent body fat by DEXA and percent body fat by 
equation were lowest for Garcia’s equation (0.1 ± 3.1% in men and 0.1 ± 4.4% in women), 
followed by Peterson’s (2.3 ± 4.1% in men and –2.4 ± 3.8% in women), then Durnin and 
Womersley’s (6.7 ± 4.5% in men and –9.8 ± 4.4% in women). Results suggested that Garcia’s 
equation was the most accurate predictor of percent body fat among equations tested and that 
Peterson’s equation was a more accurate predictor than Durnin and Womersley’s equation. 
Methodological Concerns of Prior Obesity/Headache Studies 
Existing studies on the obesity-headache relationship share two common methodological 
problems: measurement of adiposity and assessment of headache. Regarding adiposity 
measurement, all but one published study have relied solely on BMI as a measure of adiposity, 
and participants often self-reported their height and weight to derive BMI, which is less reliable 
method than directly measuring height and weight (Gorber, Tremblay, Moher, & Gorber, 2007). 
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Additionally, even when height and weight are directly measured, BMI has limited utility in 
measuring adiposity as compared to other anthropometric methods, as discussed above. 
Therefore, relying solely on BMI may not be accurately estimating potential associations 
between obesity and headache. 
 A second methodological concern pertinent to existing studies is lack of adherence to 
ICHD criteria to determine headache diagnoses. While some researchers used ICHD criteria in 
their studies, many relied on other methods such as simply asking participants if they “had severe 
headaches or migraines” or if a doctor had diagnosed them with migraine at some point (Brown 
et al, 2000; Scher et al., 2003; Ford et al., 2008; Peterlin et al., 2010; Robberstad et al., 2010; Vo 
et al., 2011). Given Bigal et al.’s (2006) and Schramm et al.’s (2013) findings that headache-
adiposity associations are more salient among those with particular headache subforms (i.e., CM 
than CTTH), and that the diagnostic criteria for some primary headache disorders have recently 
changed (ICHD-3; International Headache Society, 2013), differentiating headache diagnoses 
using validated criteria is of particular importance. 
Goals of Present Study 
In light of the limitations of prior studies, the present study sought to use established 
anthropometric measures of adiposity and strict adherence to ICHD-3 criteria to examine 
associations between adiposity and episodic primary headache disorders among young adults. A 
secondary goal was to compare the anthropometric methods in terms of their differential utility 
in predicting headache variables (i.e., frequency, severity, and disability).  
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Hypotheses 
Study goal 1: To assess whether body fat (as calculated by BMI, waist circumference, waist-to-
hip ratio, body adiposity index (BAI), and Peterson and Garcia’s skinfold equations) varies as a 
function of primary headache. 
Hypothesis 1: Participants with EM would have the highest average body fat, followed by 
those with ETTH, followed by non-headache controls, who would have the lowest 
average body fat. 
Study goal 2: To assess differences in strength of association between adiposity (as calculated by 
BMI, waist circumference, waist-to-hip ratio, body adiposity index (BAI), and Peterson and 
Garcia’s skinfold equations) and headache-related variables (frequency, severity, and disability) 
among both headache conditions (ETTH and EM). 
Hypothesis 2a: Headache frequency, severity, and disability would be positively 
associated with all measures of adiposity. 
Hypothesis 2b: Compared to BMI, other anthropometric measures (waist circumference, 
waist-to-hip ratio, BAI, and Peterson and Garcia’s skinfold equations) would yield 
stronger associations between adiposity and headache-related variables. 
Hypothesis 2c: Associations between adiposity and headache-related variables would be 
more salient among participants with EM than participants with ETTH. 
Ancillary goal: To determine if associations between adiposity and headache prevalence, 
severity, frequency, and disability still exist after controlling for scores on anxiety, depression, 
and stress measures. 
 19 
 
Hypothesis 3: After controlling for scores on anxiety, depression, and stress measures, 
positive associations between adiposity and headache prevalence, severity, frequency, 
and disability would remain for participants with EM only. 
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II.  METHODS 
Participants 
 The initial sample consisted of 133 undergraduate students age 18 years and older 
enrolled in psychology courses at the University of Mississippi who received modest course 
credit for participation. Students meeting ICHD-3 criteria for ETTH or EM and those not 
meeting criteria for any primary headache disorder were identified following their completion of 
a series of online questionnaires via Qualtrics, and they were invited by email to participate in 
the laboratory session. Assuming a small to moderate effect size (f2=.085), a power level of 0.80, 
and an alpha level of 0.05, a total sample size of 108 participants was required to determine 
whether body fat varies as a function of primary headache. 
Measures 
 Demographic Questionnaire. The Demographic Questionnaire included questions 
regarding basic demographic information such as age, gender, and race. 
Structured Diagnostic Interview for Headache – 3 (Brief Version). The Structured 
Diagnostic Interview for Headache (SDIH-3; Smitherman, Penzien, Bartley, Rhudy, & Rains, 
2014) is a modified version of the original computer-administered and well-validated SDIH 
(Andrew, Penzien, Rains, Knowlton, & McAnulty, 1992), revised to comport with ICHD-3 
diagnostic criteria. The SDIH-3 is a 17-item instrument that assesses for primary headache 
disorders by querying headache symptoms, frequency, severity, and other diagnostic 
characteristics. Additionally, the SDIH-3 includes appendix questions for assessing aura 
symptoms, cluster headache, medication overuse, and post-traumatic headache.  
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Headache Impact Test-6 (HIT-6). The HIT-6 (Kosinski et al., 2003) is a 6-item self-
report measure that assesses disability resulting from headache. Specifically, the HIT-6 assesses 
for headache impact on psychological, cognitive, occupational, and social functioning. The 6 
items provide response options on a 5-point Likert-type scale from “Never” to “Always” to 
assess for frequency and severity of impairment. Scores range from 36 to 78, with 36 indicating 
little impact and 78 indicating very severe impact of headache on functioning. Kosinski et al. 
(2003) found the HIT-6 to have internal consistency, alternate forms, and test–retest reliability 
estimates of 0.89, 0.90, and 0.80, respectively. The measure also has high discriminate validity 
across headache diagnostic groups (Kosinski et al., 2003). 
Perceived Stress Scale (PSS-10). The PSS-10 (Cohen, Kamarck, & Mermelstein, 1983; 
Cohen & Williamson, 1988) is a 10-item self-report instrument that assesses perceived stress in 
the past month. Items were designed to assess how unpredictable, uncontrollable, and overloaded 
respondents find their lives. The measure is widely used and has demonstrated strong reliability 
among college samples (i.e., Cronbach’s alpha of .89; Roberti, Harrington, & Storch, 2006). 
Generalized Anxiety Disorder-7. The Generalized Anxiety Disorder-7 (GAD-7; Spitzer, 
Kroenke, Williams, & Lowe, 2006) is a seven-item self-report measure of anxiety symptoms 
consistent with the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; 
DSM–IV–TR; American Psychiatric Association, 2000) diagnostic criteria for generalized 
anxiety disorder. The respondent answers each item on a Likert-type scale of 0 to 3, with 0 
indicating “not at all” and 3 “nearly every day.” Total scores range from 0-21; scores of 5-9 are 
indicative of mild anxiety, 10-14 of moderate anxiety, and 15 or greater of severe anxiety. 
Spitzer and colleagues (2006) demonstrated the GAD-7 to have good internal consistency (α = 
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.92) and test-retest reliability (r = .82). The GAD-7 also effectively screens other anxiety 
disorders (Kroenke, Spitzer, Williams, Monahan, & Lowe, 2007). 
 Patient Health Questionnaire-9. The Patient Health Questionnaire-9 (PHQ-9; Kroenke, 
Spitzer, & Williams, 2001) is a nine-item self-report measure of depressive symptoms consistent 
with DSM-IV-TR (2000) diagnostic criteria for major depressive disorder. The respondent 
answers each item on a Likert-type scale of 0 to 3, with 0 indicating “not at all” and 3 “nearly 
every day.” Total scores range from 0-27; scores of 5-9 are indicative of mild depression, 10-14 
of moderate depression, 15-19 of moderately severe depression, and 20 or greater of severe 
depression. The PHQ-9 has good internal consistency (α = .89) and test-retest reliability (r = .84) 
(Kroenke et al., 2001). 
 Anthropometric Measures of Obesity.  
Body Mass Index (BMI). The BMI is a measure of body mass calculated by body weight 
in kilograms divided by height in meters squared. 
 Waist Circumference. Waist circumference is measured midway between lower rib 
margin and superior anterior iliac spine (Garcia et al., 2005; World Health Organization, 2011). 
 Waist-to-Hip Ratio. Waist-to-hip ratio is calculated by waist circumference divided by 
hip circumference. Hip circumference is the maximal circumference at the level of the 
trochanters (Garcia et al., 2005; World Health Organization, 2011). 
Body Adiposity Index (BAI). The BAI is a measure of adiposity calculated by the 
following equation: BAI = ((hip circumference in cm)/((height in m)^1.5)–18)). 
 Skinfold Equations of Peterson et al. (2003). Peterson et al.’s (2003) skinfold equations 
are measures of percent body fat.  
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%BFnew for men = 20.94878 + (age × 0.1166) 
- (height × 0.11666) + (sum4 × 0.42696) 
- (sum42 × 0.00159) 
 
%BFnew for women = 22.18945 + (age × 0.06368) 
+ (BMI × 0.60404) - (height × 0.14520) 
+ (sum4 × 0.30919) - (sum42 × 0.00099562) 
 
Height is quantified in cm and “sum4” is the sum of the triceps, suprailiac, subscapular, and 
midthigh skinfold thicknesses. The triceps skinfold site is the midpoint of the back of the upper 
arm between the lateral projection of the acromion process of the scapula and the inferior border 
of the olecranon process of the ulna, and the measurement is taken parallel to the longitudinal 
axis of the upper arm (Lohman, Roche, & Martorell, 1988; Peterson et al., 2003). The suprailiac 
skinfold site is an oblique fold, 45° to the horizontal, along the midaxillary line immediately 
above the iliac crest. The subscapular skinfold site is below the inferior angle of the scapula, at 
45° to the vertical, along the natural cleavage lines of the skin. The midthigh skinfold site is the 
front of the thigh, halfway between the inguinal crease and the proximal border of the patella, 
and the measurement is taken along the long axis of the femur while the participant is standing 
and shifting his/her weight to the other leg (Lohman et al., 1988; Peterson et al., 2003). 
Skinfold Equations of Garcia et al. (2005). Garcia et al.’s (2005) skinfold equations are 
measures of body fat mass (BFM). 
BFMNew (kg) for men = -40.750 + {(0.397 × waist circumference) + 
[6.568 × (log triceps SF + log subscapular SF + log abdominal SF)]} 
 
BFMNew (kg) for women = -75.231 + {(0.512 × hip circumference) + [8.889 
× (log chin SF + log triceps SF + log subscapular SF)] + (1.905 × knee breadth)} 
Height and circumferences are quantified in centimeters, and skinfold thicknesses and knee 
breadth are quantified in millimeters. Triceps and subscapular sites are identical to those in 
Peterson et al.’s (2003) method. The abdominal skinfold site is a horizontal fold, 5 cm lateral to 
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and at the level of the midpoint of the umbilicus (Garcia et al., 2005). The chin skinfold site is a 
submental fold concentric to the chin, parallel to the longitudinal axis of the body. Knee breadth 
is the distance between the medial and lateral epicondyles of the femur, and the measurement is 
taken with sliding calipers while the participant is seated with the leg forming a right angle 
(Garcia et al., 2005). 
Procedures 
The study commenced once adequate inter-rater reliability (≥ 90% agreement) was 
obtained for each anthropometric measurement. Pre-screened participants presented individually 
for the laboratory session, at which time their headache diagnosis was confirmed with in-person 
administration of the SDIH-3. Subsequently, participants completed the aforementioned surveys, 
after which the anthropometric measurements were taken: height, weight, waist circumference, 
hip circumference, knee breadth, and skinfold thicknesses (triceps, subscapular, suprailiac, 
abdominal, midthigh, and chin). Surveys were administered before anthropometric measures to 
ensure that any stress or discomfort from anthropometric measures did not influence survey 
responses. Each participant was measured in an otherwise unoccupied room to ensure privacy.  
Statistical Analyses 
 Differences in adiposity (as measured by BMI, waist circumference, waist-to-hip ratio, 
BAI, and skinfolds) between headache groups (ETTH, EM, and control) were assessed using a 
MANOVA. Post-hoc univariate ANOVAs were used to assess potential specific differences. To 
test if adiposity was associated with increased headache frequency, severity, and disability, 
multiple linear regressions (among migraine and TTH conditions separately) were run with 
adiposity measures as “predictor” variables and frequency, severity, and disability as criterion 
variables. Significance was assessed before and after Bonferroni corrections for multiple 
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comparisons. Results of the MANOVA and regressions were predicted to indicate which 
adiposity measure would be most strongly associated with headache variables and thus of most 
potential use clinically. Regressions were repeated in hierarchical form after first entering sex, 
anxiety, depression, and stress scores in a block prior to the headache variables, in light of data 
that sex and negative affectivity influence adiposity-headache associations (Peterlin, Rosso, 
Rapoport, & Scher, 2010; Peterlin et al., 2013; Tietjen et al., 2007).  
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III.  RESULTS 
Participant Demographics and Primary Headache Diagnosis Prevalence 
 One hundred thirty-three students ages 18-54 participated in the study. Of these, 12 
provided responses to the SDIH-3 indicative of a headache diagnosis other than migraine or 
tension-type headache (n = 5) or that precluded establishing a clear diagnosis (n = 7). Four 
participants with migraine without aura, 3 participants with migraine with aura, and 3 
participants with tension-type headache reported headache frequencies of less than one day with 
headache per month. One individual was a univariate outlier on age (i.e., over 23; age = 54, 
ETTH participant). These participants were excluded from analyses to ensure distinct headache 
subgroups. The remaining 110 participants were checked for multivariate outliers by group using 
Mahalanobis distance, and 1 outlier (0.9%; migraine without aura participant) was found using a 
conservative p < .001 chi-square cut-off (Tabachnick & Fidell, 2007). After deleting this 
participant, the final sample included 109 participants: 26 (23.9% of retained sample) without 
headache, 3 (2.8%) with chronic migraine, 30 (27.5%) with episodic migraine without aura, 10 
(9.2%) with episodic migraine with aura, 3 (2.8%) with chronic tension-type headache, and 37 
(33.9%) with episodic tension-type headache. 
 Demographics of the retained sample are presented in Table 1. Nearly three-quarters 
(72.5%) of participants were female, and the mean age was 18.95 years (SD = 1.08). The 
majority of the sample was Caucasian (67.9%), followed by 19.3% African American, 5.5% 
Asian, 4.6% multiracial or other, and 2.8% Hispanic/Latino. Based on BMI ranges established by 
the Centers for Disease Control, 1.8% of participants were underweight, 62.4%were of a healthy 
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weight, 23.9% were overweight but not obese, and 11.9% were obese. Using waist 
circumference as an indicator of obesity and cutoffs established by the World Health 
Organization, 8.3% of the sample was obese. Participants with a primary headache disorder 
reported, on average, experiencing 5.0 headache days per month (SD = 5.1), a pain severity of 
5.7 out of 10 (SD = 1.7), mean disability on the HIT-6 of 56.9 (SD = 7.5), GAD-7 score of 6.08 
(SD = 4.0), PHQ-9 score of 6.3 (SD = 4.5), and PSS-10 score of 17.3 (SD = 6.2). More than three 
quarters (79.5%) of those with headache reported moderate or higher disability on the HIT-6.  
Differences in Adiposity 
 Participants with a primary headache disorder had an average waist circumference of 
76.3 cm (SD = 13.0), BMI of 24.5 (SD = 5.7), waist to hip ratio of .78 (SD = .07), BAI of 27.5 
(SD = 5.6), percent body fat via Peterson’s equations of 32.8% (SD = 7.3), and body fat mass 
(kg) via Garcia’s equations of 21.2 (SD = 9.6). Contrary to hypotheses, a MANOVA did not 
reveal significant differences between the three headache groups (control, migraine, TTH) for 
adiposity. The Wilks’ Lambda multivariate criterion for overall group differences was not 
significant; F(12, 202) = .979, p = .47.  Exploratory post-hoc analyses revealed no significant 
effect for any single adiposity variable, including waist circumference (p = .54), BMI (p = .98), 
waist to hip ratio (p = .21), BAI (p = .49), Peterson’s percent fat equations (p = .35), and Garcia’s 
body fat mass equations (p = .90). A subsequent MANCOVA assessed whether differences in 
adiposity between groups would exist when controlling for sex, depression, anxiety, and 
perceived stress. As with the MANOVA results, the MANCOVA after controlling for these 
covariates was also not significant, Wilks’ Lambda F(12, 194) = .914, p = .70. 
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Adiposity as a Predictor of Headache Disability, Frequency, and Pain Severity 
 A series of multivariate linear regressions assessed whether any of the six adiposity 
measures predicted HIT-6 scores, headache frequency, or self-reported headache pain severity. 
Separate regressions were run for participants with TTH and migraine. Results were not 
significant for migraineurs, although R-squared values indicated that adiposity accounted for 
11% (p = .62), 13% (p = .51), and 10% (p = .67) of the variance in headache severity, frequency, 
and disability, respectively. Among participants with TTH, adiposity was not a significant 
predictor of headache severity (R-squared = 8%; p = .82) or frequency (R-squared = 21%; p = 
.23), but adiposity was a significant predictor of headache disability (R-squared = 39%; p = 
.009). After controlling for sex, anxiety, depression, and stress, results remained the same with 
all adiposity measures insignificant predictors of headache variables, with the exception of 
disability among those with TTH (R-squared = 48%; p = .020). To control for multiple 
comparisons using Bonferroni correction, a p-value of less than .008 was required for 
significance (.05 ÷ 6 comparisons). Thus, after employing Bonferroni correction, adiposity was 
no longer a significant predictor of headache disability among participants with TTH. Regression 
results are presented in Tables 2-4. 
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IV.  DISCUSSION 
 Existing literature has established a positive association between BMI and risk for 
migraine, particularly chronic migraine, among adults under age 45 years (Bigal and Lipton, 
2006; Ford et al., 2008; Peterlin et al., 2010; Vo et al., 2011).  Adiposity’s association with 
prevalence of TTH and episodic migraine is less clear, with previous studies yielding 
contradicting results (Bigal et al. 2006; Peterlin et al., 2013). However, previous studies have not 
consistently adhered to ICHD diagnostic criteria to establish primary headache diagnoses nor 
used measures of adiposity other than BMI. The present study sought to use established 
anthropometric measures of adiposity and a diagnostic headache interview to determine 
associations between adiposity and primary headache disorders of migraine and TTH. Based on 
findings of previous studies, we hypothesized that adiposity would differ between control (non-
headache), migraine, and TTH groups.  
Adiposity across Diagnostic Groups 
 Contrary to hypotheses, no differences in adiposity were found between those without 
headache, those with migraine, and those with TTH. Based on a priori power analysis, the 
present sample size was sufficient to detect statistically significant differences of small to 
moderate size between groups. Anthropometric measures of adiposity employed in this study 
have empirical support, and headache conditions were determined via strict adherence to ICHD 
criteria. Given a sufficient sample size and sound methods, results suggest a lack of association 
between adiposity and primary headache disorders. Existing literature has provided support both 
for and against a relationship between adiposity and episodic migraine, and the present findings 
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are consistent with those of Bigal et al. (2006), who found that the prevalence of EM did not 
significantly differ as a function of BMI. Consistent findings may be due to similarities in the 
sample composition. Specifically, 3% of participants in Bigal et al.’s (2006) study were 
underweight, 51% were of healthy weight, 31% were overweight, and 15% were obese. This 
BMI distribution is very similar to that of the present study, while Peterlin et al.’s (2013) sample 
consisted of 3% underweight, 37% healthy weight, 34% overweight, and 26% obese. Possibly 
Peterlin et al. (2013) found EM prevalence and BMI to be positively associated due to their 
sample’s higher proportion of overweight and obese participants. Additionally, Peterlin et al.’s 
(2013) sample had an average participant age of 46.6 years, while Bigal et al.’s (2006) average 
participant age was 38.7 years – a mean closer to that of the present study.  
The finding that adiposity is not associated with EM is in contrast to the consistent 
positive associations observed between obesity and chronic headache subforms (Bigal and 
Lipton, 2006; Scher et al., 2003; Schramm et al., 2013), suggesting that headache frequency is 
more strongly associated with obesity than is migraine per se. Only 7% of migraineurs in the 
present study had chronic migraine, and only 7.5% of TTH sufferers had CTTH. Thus, although 
the present study did not find any associations between adiposity and primary headache disorder 
prevalence, these conclusions are applicable to young adults with episodic migraine or TTH, as 
associations with chronic headache conditions cannot be established. 
Adiposity as a Predictor of Headache Variables 
 Based on findings of previous studies that headache frequency, severity, and disability 
may increase as a function of BMI (Bigal et al., 2006; Bigal and Lipton, 2006; Tietjen, et al., 
2007), the adiposity measures in this study were expected to be positively associated with 
headache frequency, severity, and disability. However, contrary to hypotheses, only small and 
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largely non-significant associations were found between the adiposity measures and headache 
variables among migraine and TTH groups. After controlling for sex, depression, anxiety, and 
perceived stress levels, results remained similar. These contradicting findings are likely due to 
the fact that the present sample consisted of primarily episodic headache subforms, whereas 
studies that found associations between adiposity and headache variables had higher proportions 
of chronic headache patients. However, Bigal et al., (2006) found that headache severity and 
disability were positively associated with BMI among episodic migraineurs, although they relied 
on self-reported BMI as the only measure of adiposity. Because the literature on adiposity 
measurement indicates the anthropometric methods in the current study are more accurate than 
BMI, a positive association between obesity and headache variables may be a spurious result that 
is not present when accurate measures of adiposity are employed. 
 Because the adiposity measures used in this study are highly correlated with “gold 
standard” methods, BAI, waist circumference, waist-to-hip ratio, and skinfold equations by 
Peterson and Garcia were expected to account for more variance in headache variables than BMI 
alone. Findings did not support this hypothesis; no consistent pattern was revealed when 
comparing the standardized betas for each adiposity measure, and none were statistically 
significant. 
 Adiposity in Episodic vs. Chronic Headache  
As the present study found no relationships between adiposity and episodic migraine and 
TTH, multiple possible interpretations exist. One interpretation is that these findings, in 
conjunction with prior studies on adiposity and chronic headache, suggest that obesity 
characterizes chronic but not episodic primary headache disorders (Bigal and Lipton, 2006; 
Schramm et al., 2013). However, if adiposity is a risk factor for headache chronification, then 
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headache frequency would be expected to have a stronger relationship with adiposity than was 
observed in the present study. Previous studies have found a positive association between BMI 
and migraine frequency (Bigal and Lipton, 2006; Bigal et al., 2006; Tietjen et al., 2007), 
although the association was no longer significant when controlling for anxiety and depression, 
conditions common among individuals who are obese or who have migraine (Tietjen et al., 
2007). Given the existing literature and current findings, a second interpretation is that the 
temporal direction of any relationship between adiposity and headache may be opposite than 
hypothesized; that is, rather than obesity being a risk factor for headache chronicity, people with 
chronic headache may subsequently gain weight and/or become obese (e.g., as a result of 
medication side effects, reductions in physical activity, and hypothalamic alterations). This 
hypothesis is consistent with the findings of Vo et al. (2011), who found women with migraine 
as children had 1.67-fold increased odds of gaining at least 22 pounds during adulthood. In 
contrast, Scher et al. (2003) found obese participants with episodic headache at baseline to be at 
increased risk of progressing to chronic daily headache at 11-month follow-up. Clearly, more 
longitudinal research is needed to determine the direction of the adiposity-headache relationship. 
Another goal of this study was to determine which measure of adiposity had the strongest 
association with headache variables and thus would have the most clinical utility. Given null 
findings and insignificant associations of all adiposity measures with headache variables, the 
present study does not suggest any of the included adiposity measures to have much clinical 
utility in predicting headache variables for young adults with episodic migraine or episodic 
tension-type headache. However, this study does not speak to their utility in predicting headache 
variables for chronic headache patients, who comprised a small majority of the present sample, 
or treatment-seeking patients. Given findings in previous studies and the strong methodology of 
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the present study, it seems most likely that obesity-headache associations are unique to chronic 
migraine and chronic tension-type headache; thus future research with chronic headache patients 
may find clinical utility in the adiposity measures used in this study. 
Limitations and Future Directions 
 Strengths of this study include the use of well-established anthropometric measures of 
adiposity other than BMI, examiner-measured adiposity instead of reliance on participant self-
report, and strict adherence to ICHD diagnostic criteria via in-person structured interviews 
(SDIH-3). However, this study includes several limitations, and caution should be used when 
generalizing these findings to the population. First, the final sample consisted of 109 participants, 
which although sufficient assuming a small-to-moderate effect size, would be insufficient for a 
smaller effect size. Thus, it is possible that a larger sample would have yielded significant results 
and positive associations between adiposity and headache variables. However, p-values for the 
majority of statistical analyses were far short of and did not even “trend” toward significance. 
Even if larger samples yielded statistically significant differences, group differences in adiposity 
would likely be quite small and not of clinical significance. Second, all participants were non-
treatment-seeking undergraduate students between the ages of 18 and 23, and thus results may 
not generalize to older or clinical populations. However, young adults are a desirable population 
in headache research, given their high prevalence of primary headache disorders and low 
frequency of variables that complicate conclusions from headache studies, such as long histories 
of medication overuse and chronification (Smitherman et al., 2011). Additionally, participants 
with extremely low headache frequencies (<1 day per month) were omitted from analyses, and 
retained EM and ETTH participants had an average of approximately four headache days per 
month. Nearly 80% of participants with headache reported moderate to severe headache-related 
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disability, suggesting the majority of this young non-clinical sample had headache that 
significantly affected their lives. Third, although this study included a variety of adiposity 
measures with empirical support, for financial and practical reasons it did not include a “gold 
standard” method of assessing body composition such as DEXA or MRI and CT. Thus, it is 
possible that different associations would have been found between adiposity and headache 
variables had a more accurate measure of adiposity been employed. However, given that 
previous studies found the anthropometric methods used in this study to have high correlations 
with “gold standard” methods and the four-component model, and given this study’s sufficient 
sample size based on power analysis, the anthropometric methods used likely would have 
detected headache-adiposity associations if present (Bergman et al., 2012; Clasey et al., 1999; 
Garcia et al., 2005; Johson et al., 2012; Kamel et al., 1999; Peterson et al., 2003). Finally, the 
proportion of participants who were overweight or obese (35.8%) was lower than that of the 
national average (68.5%), and thus findings may not be generalizable to the larger population.  
 Given the established relationship between BMI and migraine in the existing literature, 
future studies are needed that assess the utility of these anthropometric measures of adiposity 
among individuals with chronic migraine and TTH, as well as those using DEXA or MRI and 
CT to further examine the relationships between adiposity and primary headache disorders. 
Studies including older adults or treatment-seeking samples would yield results applicable to a 
wider range of people and those with larger samples would also be able to detect small effects of 
adiposity on headache variables. Another area of needed research are longitudinal studies 
examining adiposity as a risk factor for headache chronification. Such findings would have 
preventative and treatment implications for clients presenting with headache, such as 
determining the value of integrating weight monitoring or weight loss interventions within 
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existing headache treatments (see Bond, Roth, Nash, & Wing, 2011). Currently, Bond et al. 
(2013) are conducting a RCT examining the effects of a behavioral weight loss program on 
migraine frequency among women, and other studies of this type will further clarify the role of 
obesity weight loss in migraine.  
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Table 1 
Demographics and Average Adiposity 
 
 No 
Headache 
N = 26 
Chronic 
migraine 
 
N = 3 
Episodic 
migraine 
 
N = 30 
Episodic 
migraine 
w/ aura 
N = 10 
Chronic 
TTH 
 
N = 3 
Episodic 
TTH 
 
N = 37 
Demographics 
Age                   
M 
(SD) 
19.0 
(1.2) 
18.7 
(0.6) 
19.0 
(1.0) 
18.5 
(0.5) 
18.7 
(0.6) 
19.1 
(1.2) 
Female 
N 
% 
15 
(58%) 
2 
(67%) 
26 
(87%) 
10 
(100%) 
3 
(100%) 
23 
(62%) 
Male 
N 
% 
11 
(42%) 
1 
(33%) 
4 
(13%) 
0 
(0%) 
0 
(0%) 
14 
(38%) 
Caucasian 
N 
% 
17 
(65%) 
2 
(67%) 
14 
(47%) 
8 
(80%) 
3 
(100%) 
30 
(81%) 
Headache 
Days/Month 
M 
(SD) 
N/A 
20.7 
(8.1) 
4.2 
(3.4) 
3.8 
(3.0) 
17.3 
(2.3) 
3.8 
(2.9) 
HIT-6 Score 
M 
(SD) 
N/A 
65.0 
(8.1) 
60.5 
(6.7) 
60.8 
(6.1) 
61.3 
(1.5) 
52.0 
(6.0) 
Pain Severity 
M 
(SD) 
N/A 
5.3 
(1.5) 
6.6 
(1.4) 
7.5 
(1.6) 
5.5 
(1.3) 
4.6 
(1.2) 
PHQ-9 Score 
M 
(SD) 
3.8 
(3.3) 
10.3 
(8.4) 
7.1 
(4.8) 
6.5 
(6.9) 
7.3 
(2.5) 
5.2 
(2.7) 
GAD-7 Score 
M 
(SD) 
3.5 
(3.6) 
10.3 
(6.8) 
6.6 
(4.0) 
4.8 
(4.4) 
4.7 
(3.1) 
5.8 
(3.7) 
PSS-10 Score 
M 
(SD) 
12.4 
(4.8) 
21.3 
(6.0) 
18.9 
(6.8) 
14.7 
(6.9) 
21.0 
(5.3) 
16.1 
(5.1) 
 
Adiposity Measures 
Waist 
Circumference  
M 
(SD) 
77.8 
(9.6) 
66.9 
(5.6) 
77.6 
(16.0) 
69.7 
(7.4) 
66.7 
(6.5) 
78.5 
(11.4) 
BMI 
M 
(SD) 
24.8 
(4.6) 
21.1 
(2.7) 
25.5 
(7.6) 
22.6 
(3.8) 
21.6 
(2.5) 
24.8 
(4.5) 
Waist to Hip 
Ratio 
M 
(SD) 
.81 
(.06) 
.75 
(.06) 
.79 
(.08) 
.75 
(.04) 
.72 
(.05) 
.80 
(.06) 
BAI 
M 
(SD) 
26.2 
(4.4) 
24.0 
(2.5) 
28.2 
(7.1) 
27.5 
(3.9) 
28.8 
(2.8) 
27.0 
(4.9) 
Peterson Percent 
Body Fat 
M 
(SD) 
31.1 
(7.1) 
26.8 
(6.3) 
34.4 
(8.7) 
32.9 
(5.4) 
33.2 
(4.5) 
31.9 
(6.6) 
Garcia Body Fat 
Mass (kg) 
M 
(SD) 
20.3 
(8.5) 
12.9 
(4.4) 
22.6 
(11.3) 
19.1 
(8.6) 
18.8 
(6.2) 
21.6 
(8.6) 
Note. TTH = tension-type headache, M = mean, SD = standard deviation, N = number of participants, 
% = percentage of participants. Waist circumference is in centimeters; Garcia body fat mass is in 
kilograms. 
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Table 2 
 
Adiposity as a Predictor of Headache Severity 
 
Migraine (n = 43) 
 Coefficients Model Summary 
 B SE Beta t P-
value 
R2 Adjusted 
R2 
SE F P-
value 
Waist 
Circumference 
.10 .13 1.00 .81 .42      
 
BMI 
 
 
-.14 
 
.16 
 
-.62 
 
-.88 
 
.38 
     
Waist to Hip 
Ratio 
-8.45 12.10 -.43 -.70 .49      
           
BAI 
 
-.07 .13 -.30 -.55 .59      
Peterson 
equations 
.15 .11 .81 1.40 .17      
 
Garcia 
equations 
 
-.10 
 
.11 
 
-.69 
 
-.89 
 
.38 
     
 .11 -.04 1.51 .74 .62 
 
Tension-Type Headache (n = 40) 
 Coefficients Model Summary 
 B SE Beta t P-
value 
R2 Adjusted 
R2 
SE F P-
value 
Waist 
Circumference 
.03 .08 .27 .37 .72      
           
BMI 
 
-.19 .13 -.69 -1.42 .17      
Waist to Hip 
Ratio 
1.35 7.12 .07 .19 .85      
           
BAI 
 
.04 .10 .15 .35 .73      
Peterson 
equations 
-.02 .08 -.08 -.21 .84      
           
Garcia 
equations 
.04 .09 .28 .45 .66      
      .08 -.09 1.25 .48 .82 
 
Note: n = number of participants, SE = standard error, BMI = body mass index, BAI = body adiposity 
index. 
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Table 3 
Adiposity as a Predictor of Headache Frequency 
 
Migraine (n = 43) 
 Coefficients Model Summary 
 B SE Beta t P-
value 
R2 Adjusted 
R2 
SE F P-
value 
Waist 
Circumference 
-.47 .48 -1.20 -.99 .33      
           
BMI 
 
-.26 .58 -.31 -.45 .66      
Waist to Hip 
Ratio 
63.60 45.18 .86 1.41 .17      
           
BAI 
 
.60 .48 .68 1.27 .21      
Peterson 
equations 
-.20 .40 -.29 -.51 .61      
           
Garcia 
equations 
.16 .40 .30 .40 .70      
      .13 -.015 5.65 .90 .51 
 
Tension-Type Headache (n = 40) 
 Coefficients Model Summary 
 B SE Beta t P-
value 
R2 Adjusted 
R2 
SE F P-
value 
Waist 
Circumference 
-.23 .27 -.57 -.85 .40      
           
BMI 
 
-.25 .47 -.24 -.53 .60      
Waist to Hip 
Ratio 
1.83 25.15 .03 .07 .94      
           
BAI 
 
.43 .36 .45 1.19 .24      
Peterson 
equations 
-.35 .26 -.48 -1.31 .20      
           
Garcia 
equations 
.25 .31 .46 .80 .43      
      .21 .06 4.43 1.45 .23 
 
Note. n = number of participants, SE = standard error, BMI = body mass index, BAI = body adiposity 
index. 
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Table 4 
 
Adiposity as a Predictor of Headache Disability 
 
Migraine (n = 43) 
 Coefficients Model Summary 
 B SE Beta t P-
value 
R2 Adjusted 
R2 
SE F P-
value 
Waist 
Circumference 
.18 .56 .39 .32 .75      
           
BMI 
 
-.76 .68 -.79 -1.12 .27      
Waist to Hip 
Ratio 
27.32 52.78 .32 .52 .61      
           
BAI 
 
.28 .56 .27 .50 .62      
Peterson 
equations 
-.16 .47 -.19 -.34 .74      
           
Garcia 
equations 
.10 .47 .16 .21 .84      
      .10 -.05 6.60 .68 .67 
 
Tension-Type Headache (n = 40) 
 Coefficients Model Summary 
 B SE Beta t P-
value 
R2 Adjusted 
R2 
SE F P-
value 
Waist 
Circumference 
-.18 .33 -.33 -.56 .58      
           
BMI 
 
-.76 .57 -.53 -1.34 .19      
Waist to Hip 
Ratio 
.55 30.43 .01 .02 .99      
           
BAI 
 
.61 .44 .46 1.39 .18      
Peterson 
equations 
-.06 .32 -.06 -.18 .86      
           
Garcia 
equations 
.27 .38 .36 .72 .48      
      .39 .28 5.36 3.51 .009* 
 
Note. n = number of participants, SE = standard error, BMI = body mass index, BAI = body adiposity 
index. *p < .01. 
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